Mimedx (MDXG) Net Income towards Common Stockholders (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.59% |
| Sep 30, 2024 | -55.29% |
| Jun 30, 2024 | 94.47% |
| Mar 31, 2024 | -79.79% |
| Dec 31, 2023 | 534.16% |
| Sep 30, 2023 | -6.03% |
| Jun 30, 2023 | 307.47% |
| Mar 31, 2023 | -144.58% |
| Dec 31, 2022 | 180.57% |
| Sep 30, 2022 | 19.21% |
| Jun 30, 2022 | -3.49% |
| Mar 31, 2022 | -763.73% |
| Dec 31, 2021 | 64.27% |
| Sep 30, 2021 | -19.44% |
| Jun 30, 2021 | 66.74% |
| Mar 31, 2021 | 45.46% |
| Dec 31, 2020 | 65.26% |
| Sep 30, 2020 | -514.01% |
| Jun 30, 2020 | -75.61% |
| Mar 31, 2020 | 35.51% |
| Dec 31, 2019 | -160.39% |
| Sep 30, 2019 | 171.93% |
| Jun 30, 2019 | -29.66% |
| Mar 31, 2019 | 63.36% |
| Dec 31, 2018 | -20,250.56% |
| Sep 30, 2018 | -109.87% |
| Jun 30, 2018 | -60.94% |
| Mar 31, 2018 | -50.72% |
| Dec 31, 2017 | -30.94% |
| Sep 30, 2017 | 123.09% |
| Jun 30, 2017 | 5.62% |
| Mar 31, 2017 | 194.38% |
| Dec 31, 2016 | -283.77% |
| Sep 30, 2016 | 68.15% |
| Jun 30, 2016 | 65.00% |
| Mar 31, 2016 | -91.05% |
| Dec 31, 2015 | 104.21% |
| Sep 30, 2015 | 20.64% |
| Jun 30, 2015 | 32.86% |
| Mar 31, 2015 | 6.63% |
| Dec 31, 2014 | 3.59% |
| Sep 30, 2014 | 1,048.72% |
| Jun 30, 2014 | 57.70% |
| Mar 31, 2014 | 35.39% |
| Dec 31, 2013 | -364.67% |
| Sep 30, 2013 | 59.45% |
| Jun 30, 2013 | 53.26% |
| Mar 31, 2013 | -0.90% |
| Dec 31, 2012 | 61.94% |
| Sep 30, 2012 | -467.07% |
| Jun 30, 2012 | 31.96% |
| Mar 31, 2012 | 57.56% |
| Dec 31, 2011 | -45.96% |
| Sep 30, 2011 | 29.47% |
| Jun 30, 2011 | 25.21% |